2022
DOI: 10.1002/ange.202210001
|View full text |Cite
|
Sign up to set email alerts
|

A Carbon‐Carbon Bond Cleavage‐Based Prodrug Activation Strategy Applied to β‐Lapachone for Cancer‐Specific Targeting

Abstract: Prodrugs are one of the most common strategies for the design of targeted anticancer agents. However, their application is often hampered by the modifiable groups available on parent drugs. Herein, a carbon-carbon (CÀ C) bond cleavage-based prodrug activation strategy is reported, which was successfully used to design prodrugs of β-lapachone (β-lap), an ortho-quinone natural product without traditional modifiable groups for the construction of CÀ N/CÀ O bond cleavage-based prodrugs. The designed β-lap prodrug … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
2

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 66 publications
0
5
0
Order By: Relevance
“…In this work, we study the prodrug design for β -lapachone, a natural product with extensive anticancer activity. In the original study [14], the authors use DFT and select M06-2X functional to calculate the energy barrier. The results show that the energy barrier for C-C bond cleavage is small enough for the chemical reaction to proceed spontaneously under physiological temperature conditions.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…In this work, we study the prodrug design for β -lapachone, a natural product with extensive anticancer activity. In the original study [14], the authors use DFT and select M06-2X functional to calculate the energy barrier. The results show that the energy barrier for C-C bond cleavage is small enough for the chemical reaction to proceed spontaneously under physiological temperature conditions.…”
Section: Resultsmentioning
confidence: 99%
“…Among various prodrug activation strategies [14][15][16][17][18][19][20][21], that based on the cleavage of carboncarbon (C-C) bonds is particularly innovative. It is a novel strategy with applicability to drugs without traditional modifiable groups.…”
Section: Carbon-carbon Bond Cleavage In Prodrug Activation Strategymentioning
confidence: 99%
See 1 more Smart Citation
“…Accordingly, transplantation of H 2 O 2 -affording agents in CDT platforms is a frequent strategy to enhance its antitumor effect. Typically, glucose oxidase or β-lapachone (β-lap) could increase endogenous H 2 O 2 dose via mediating or involving the catalytic reactions with substrates (e.g., glucose) or enzymes (e.g., nicotinamide adenine dinucleotide (NAD)(P)H: quinone oxidoreductase-1, NQO1) in the tumor microenvironment [ 14 , 15 ], which are used as the natural donors of H 2 O 2 and potential enhancer of CDT. Nevertheless, almost all of these catalytic reactions need O 2 to participate directly or indirectly, and the actual hypoxia and continuous depletion of O 2 further impedes CDT effect [ 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Accordingly, transplantation of H 2 O 2 -affording agents in CDT platforms is a frequent strategy to enhance its antitumor effect. Typically, glucose oxidase or β-lapachone (β-lap) could increase endogenous H 2 O 2 dose via mediating or involving the catalytic reactions with substrates (e.g., glucose) or enzymes (e.g., nicotinamide adenine dinucleotide (NAD)(P)H: quinone oxidoreductase-1, NQO1) in the tumor microenvironment [14,15], which are used as the natural donors of H 2 O 2 and potential enhancer of CDT. Nevertheless, almost all of these catalytic reactions need O 2 to participate directly or indirectly, and the actual hypoxia and continuous depletion of O 2 limits the su cient supplement of H 2 O 2 and impedes CDT effect [16].…”
Section: Introductionmentioning
confidence: 99%